Early clinical trials of a Covid-19 vaccine that is among those currently in late-stage testing have shown favorable responses among participants in terms of antibody and immune cell responses. Mainz, Germany-based BioNTech and New York-based Pfizer said late Thursday afternoon that among U.S. Phase I student participants who received the …
Read More »Pfizer, BioNTech of Germany releases new data on Covid-19 vaccine
